← Insider buys
ALLO

Allogene Therapeutics, Inc. · Healthcare

Chief Financial Officer Geoffrey M. Parker sold $49K of Allogene Therapeutics, Inc.

Sold$48,698
$1.34Price
36,342Shares
−3%Stake

What ALLO did after the filing

Prices for ALLO after this filing aren't in yet.

Traded Wed, Oct 21. Filed Fri, Oct 23, 4:48 PM ET, after the close. Not investment advice.